Sri Rezeki Hadinegoro
Biographic Data
| ID | 10037601 |
|---|---|
| NAME | Sri Rezeki Hadinegoro |
| GIVEN NAMES | Sri Rezeki |
| FAMILY NAME | Hadinegoro |
| SIGNATURE | HADINEGORO S R |
| AFFILIATIONS | University of Indonesia |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
How can new TB vaccines be effectively introduced in Indonesia? Insights from diverse stakeholders
New adult tuberculosis (TB) vaccines are in clinical trials and may be licensed as soon as 2028. However, vaccine rollout requires addressing multiple contextual factors beyond clinical trial findings. This study explored stakeholders’ perspectives on the introduction of a new TB vaccine in Indonesia. We used a mixed-methods approach combining a stakeholder consultation in Jakarta (13/03/2025) among 28 participants with diverse expertise and foll…
Addressing knowledge, attitude and practice gaps for effective dengue management strategies in Indonesia
Background: Dengue is a significant public health issue in Indonesia, facing a substantial year-round disease burden and rising incidence. However, comprehensive assessments of Knowledge, Attitudes, and Practices (KAP) regarding dengue in the Indonesian adult population are limited. This study provides one of the first comprehensive evaluations of KAP in Indonesia, aiming to inform integrated dengue management programs. Methods: This study utiliz…
No prominent works on this page.
Addressing knowledge, attitude and practice gaps for effective dengue management strategies in Indonesia
Background: Dengue is a significant public health issue in Indonesia, facing a substantial year-round disease burden and rising incidence. However, comprehensive assessments of Knowledge, Attitudes, and Practices (KAP) regarding dengue in the Indonesian adult population are limited. This study provides one of the first comprehensive evaluations of KAP in Indonesia, aiming to inform integrated dengue management programs. Methods: This study utiliz…
How can new TB vaccines be effectively introduced in Indonesia? Insights from diverse stakeholders
New adult tuberculosis (TB) vaccines are in clinical trials and may be licensed as soon as 2028. However, vaccine rollout requires addressing multiple contextual factors beyond clinical trial findings. This study explored stakeholders’ perspectives on the introduction of a new TB vaccine in Indonesia. We used a mixed-methods approach combining a stakeholder consultation in Jakarta (13/03/2025) among 28 participants with diverse expertise and foll…
Public health (2 works) · Clinical trial (1 work) · Cross-sectional study (1 work) · Dengue and Mosquito Control Research (1 work) · Dengue fever (1 work) · Dengue vaccine (1 work) · Dengue virus (1 work) · Environmental health (1 work) · Geography (1 work) · Health care (1 work)